—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Sanofi SA (SAN.PA) — chart, structure and Closelooknet read

The Closelooknet read

Sanofi researches, develops and manufactures medicines and vaccines, covering immunology, rare diseases, neurology, oncology and other therapeutic areas. Its vaccine business includes childhood shots for polio, pertussis and Hib, plus respiratory syncytial virus protection and combination vaccines against hepatitis, typhoid, yellow fever and rabies.

Detail below: the desk's view, the earnings record, peers and the company snapshot; daily prices on the price-history tab. Research diary readings, not advice.

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for SAN.PA, from the same nightly bakes the boards use. Research diary readings, not advice.

Versus its index Euro-AI 50 — the name, its sleeve and the index over day, week and month

Versus its index

The name against its Closelooknet index and its own sleeve — equal-weight, nightly closes.

Euro-AI 50 · as of 2026-11-06

DayWeekMonth3 months
SAN.PA−1.7%+4.2%+17.2%+10.2%
Euro-AI 50−0.2%−4.2%−5.8%—

Against the index: 8.4 pts ahead on the week, 23.0 pts ahead on the month.

Returns from the index workers’ nightly closes; equal-weight sleeves. A relative reading from the research diary, not advice.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 47/100 · S&P 500 fund at 48, above its 200-day averageEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-11-06
  • Factor regime Defensive rotation — low-vol leading, regime-change watchMomentum against low volatility (SPMO / SPLV): below its 50-day trend, 60th percentile of the window, -22.8% over 20 sessions. Factor regime → 2026-11-06
  • Sovereign pressure Index -1.91 · down 2.45 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-11-06
Who it is priced against Drug Manufacturers - General · 8 names with week and year-to-date

Peer group

Drug Manufacturers - General

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against SAN.PA on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Sanofi SA

SAN.PA in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Sanofi researches, develops and manufactures medicines and vaccines, covering immunology, rare diseases, neurology, oncology and other therapeutic areas. Its vaccine business includes childhood shots for polio, pertussis and Hib, plus respiratory syncytial virus protection and combination vaccines against hepatitis, typhoid, yellow fever and rabies. The company also runs a wide set of research collaborations with smaller biotech and AI-drug-discovery partners to widen its pipeline. Sanofi is headquartered in Paris, France.
Where it sits in the stack
Sanofi carries no seat in Rubin or Halo, so it sits outside the diary's AI build-out stack; it belongs to the Healthcare sector of our wider universe.
Who it is priced against
Closelooknet's peer group places it with scored healthcare names in the same sector, including Argen-X, Eli Lilly, Medpace, BeiGene, UCB, Fisher & Paykel Healthcare and Globus Medical; the market also compares it with Novartis.
Why Closelooknet tracks it
Sanofi holds a seat in our Euro-AI 50 index and carries a Closelooknet score, with quality the strongest module and momentum the weakest.
What the diary watches
The diary watches whether the pipeline built through its many research collaborations turns into stronger growth, given how far growth trails quality in its current score.

Sanofi SA (SAN.PA) trades on the PA exchange in France. Constituent of Euro-AI 50.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Dividends and capital return trailing yield 4.92%, annual · buybacks 5.03 bn EUR in FY2025

Dividends and capital return

What SAN.PA pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 4.12 EUR per share · a 4.92% yield on the 2026-11-06 close 1 distribution, paid once a year 2026-11-06
  • Change on the year +5.1% against the prior twelve months prior twelve months 3.92 EUR per share
  • Last distribution 4.12 EUR per share as the price series records it, within days of the ex-date 2026-05-05
  • By calendar year 2024: 3.76 EUR (partial) · 2025: 3.92 EUR · 2026: 4.12 EUR to date first distribution recorded in the three-year window: 2024-05-13
  • Dividends paid, FY2025 4.77 bn EUR 46% of earnings
  • Buybacks, FY2025 5.03 bn EUR 5.0% of today's market value
  • Share count −2.5% in FY2025
  • Capital returned 9.80 bn EUR · 109% of free cash flow dividends and buybacks together, against the year’s free cash flow

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-11-07

Quick answers

What is Sanofi SA (SAN.PA)?

Sanofi SA trades as SAN.PA on the PA exchange (France) in the Closelooknet research universe, as of the registry build of 2026-11-07.

Is SAN.PA in a Closelooknet index?

Yes — Sanofi SA is a constituent of Euro-AI 50, as of 2026-11-07.

Where does SAN.PA trade against its moving averages?

Sanofi SA trades 13.5% above its 50-day and 12.3% above its 200-day moving average (12.1% above its 20-day). As of 2026-11-05 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How is SAN.PA doing against its Closelooknet index?

Over the past month Sanofi SA is +17.2% against −5.8% for the Euro-AI 50 — 23.0 points ahead of its index, as of 2026-11-06. The “Versus its index” table on this page carries the day, the week and the month for the name, its sleeve and the index.

How does Sanofi SA compare with its peers?

Against its peer group (Drug Manufacturers - General), Sanofi SA (SAN.PA) sits 2.1% below its 52-week high, 13.5% above its 50-day average; Eli Lilly and Company (LLY) is 6.1% below, Amgen Inc (AMGN) is 4.9% below, AstraZeneca PLC (AZN.L) is 9.9% below, as of 2026-11-05. Put any of them next to SAN.PA in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.

What does Sanofi SA do?

Sanofi researches, develops and manufactures medicines and vaccines, covering immunology, rare diseases, neurology, oncology and other therapeutic areas. Its vaccine business includes childhood shots for polio, pertussis and Hib, plus respiratory syncytial virus protection and combination vaccines against hepatitis, typhoid, yellow fever and rabies. The company also runs a wide set of research collaborations with smaller biotech and AI-drug-discovery partners to widen its pipeline. Closelooknet's peer group places it with scored healthcare names in the same sector, including Argen-X, Eli Lilly, Medpace, BeiGene, UCB, Fisher & Paykel Healthcare and Globus Medical; the market also compares it with Novartis. (Company snapshot of 2026-09-17.)

Where does Sanofi SA sit in the AI build-out?

Sanofi carries no seat in Rubin or Halo, so it sits outside the diary's AI build-out stack; it belongs to the Healthcare sector of our wider universe. Sanofi holds a seat in our Euro-AI 50 index and carries a Closelooknet score, with quality the strongest module and momentum the weakest. (Company snapshot of 2026-09-17.)

Does Sanofi SA pay a dividend?

Sanofi SA has paid 4.12 EUR per share over the last twelve months, paid once a year, a trailing yield of 4.92% on the 2026-11-06 close; the last distribution recorded in the price series was 4.12 EUR on 2026-05-05. In fiscal 2025 the company paid 4.77 bn EUR in dividends and bought back 5.03 bn EUR of its own shares, 109% of that year’s free cash flow. The share count fell 2.5% over the fiscal year. As of 2026-11-06; the "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for SAN.PA, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

How to use this chart

Toolbar

  • Range — 1M to MAX on daily closes. 1D/5D switch a US stock cell to 5-minute intraday bars; index and foreign cells fall back to 1M daily with a note.
  • Grid — 1×1 up to 2×2. Cells are synchronized: pan or zoom one and the others follow the same dates; the crosshair tracks across all of them. 4 INDICES loads Rubin · HALO · AEI · AW40 side by side.
  • Type / Scale — OHLC, line or area; linear or log price axis.

Picking a series

  • Tap the box in a cell's header to browse every Closelooknet series — headline indices, sub-indices, sectors, layers of all six families — plus the constituents.
  • Or type any ticker (NVDA, 7203.T, ASML.AS …) and press Enter — it charts in the cell straight from our data lake.

Studies

  • Overlays / Oscillators rows toggle the standard set (SMA, Bollinger, RSI, MACD …) per cell.
  • Levels (stock cells) draws the structure engine's support lines — regression bands, pivot cluster, SMA-200, the active fib zone.

Drawing

  • Tap a tool (Trend, Ray, H-Line, Fib, Channel, Rect, Note), then tap the chart once per point — the shape follows your finger or cursor between taps. The chart stops panning while a tool is armed; tap the tool again to release.
  • Drawings save per symbol in this browser and travel between the terminal and the asset page.
  • Delete key removes the selected drawing · Escape cancels a half-placed one · Clear wipes the symbol.

Wave counts

  • Wave places an Elliott count: tap the origin, then each wave end. Press Enter to stop early (inside wave 3 is fine) — dotted ghost targets sketch the remaining waves at guideline ratios.
  • On stocks the scanner's machine count appears automatically in grey — it is fully editable: drag any point, double-tap a label to remove it, Delete to dismiss it for good, Adopt to bring the machine's proposal back.
  • The sequence picker switches 1-5 / A-B-C / A-E / W-X-Y-Z; 1 2 3 cycles the degree; Subdiv starts a one-degree-smaller child count inside a wave.

Sharing

  • Card exports the cell as a branded PNG — chart, drawings and levels exactly as shown.

Related in the Closelooknet universe

same Closelooknet index seat first, then Drug Manufacturers - General. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.